TailorMed, an end-to-end health tech platform providing the largest affordability network across the United States, has secured $40 million in equity and debt financing to transform medication access, affordability, and adherence. According to the company’s announcement, the funding round was backed by new investors Windham Capital Partners, Impact Fund, BrightEdge, and Samsung Next, alongside investment arms of OSF Healthcare, Providence Ventures, Inception Health, UH Ventures, UnityPoint Health Ventures, and Ballad Ventures.